Clinical Trial Imaging Market by End User (Biotechnology Companies, Pharmaceutical Companies, Medical Device Manufacturers, CROs), Modality (Ultrasound, CT, MRI, PET, X-Ray, Echocardiography), Product & Services – 2019 to 2024

$3,850.00$5,850.00

AVAIL 20% DISCOUNT ON PURCHASE OF ANY REPORT
Published on: March 23, 2020
Clear
SKU: GMS-3034 Category:

The Global Clinical Trial Imaging Market is calculated to reach USD 1.9 billion by 2025, growing at a CAGR of 7.88% during the forecast period 2020-2025. The growing incidence of chronic diseases and soaring need for better diagnostic devices are stimulating the growth of the market. Furthermore, surging demand for specialized and quality healthcare facilities to improve patient’s life is estimated to boost market growth.

Clinical Trial Imaging Market by End User (Biotechnology Companies, Pharmaceutical Companies, Medical Device Manufacturers, CROs), Modality (Ultrasound, CT, MRI, PET, X-Ray, Echocardiography), Product & Services - 2019 to 2024 1

Clinical Trial Imaging Market by End User (Biotechnology Companies, Pharmaceutical Companies, Medical Device Manufacturers, CROs), Modality (Ultrasound, CT, MRI, PET, X-Ray, Echocardiography), Product & Services - 2019 to 2024 2

Clinical Trial Imaging Market by End User (Biotechnology Companies, Pharmaceutical Companies, Medical Device Manufacturers, CROs), Modality (Ultrasound, CT, MRI, PET, X-Ray, Echocardiography), Product & Services - 2019 to 2024 3

Clinical Trial Imaging Market by End User (Biotechnology Companies, Pharmaceutical Companies, Medical Device Manufacturers, CROs), Modality (Ultrasound, CT, MRI, PET, X-Ray, Echocardiography), Product & Services - 2019 to 2024 4

Clinical Trial Imaging Market by End User (Biotechnology Companies, Pharmaceutical Companies, Medical Device Manufacturers, CROs), Modality (Ultrasound, CT, MRI, PET, X-Ray, Echocardiography), Product & Services - 2019 to 2024 5

Clinical Trial Imaging Market by End User (Biotechnology Companies, Pharmaceutical Companies, Medical Device Manufacturers, CROs), Modality (Ultrasound, CT, MRI, PET, X-Ray, Echocardiography), Product & Services - 2019 to 2024 6

Clinical Trial Imaging Market by End User (Biotechnology Companies, Pharmaceutical Companies, Medical Device Manufacturers, CROs), Modality (Ultrasound, CT, MRI, PET, X-Ray, Echocardiography), Product & Services - 2019 to 2024 7

Clinical Trial Imaging Market by End User (Biotechnology Companies, Pharmaceutical Companies, Medical Device Manufacturers, CROs), Modality (Ultrasound, CT, MRI, PET, X-Ray, Echocardiography), Product & Services - 2019 to 2024 8

1 Global Clinical Trial Imaging Market
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope

2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions

3 Global Clinical Trial Imaging Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography

4 Global Clinical Trial Imaging Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis

5 Global Clinical Trial Imaging Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies

6 Global Clinical Trial Imaging Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.1.1
6.2.2 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes

7 Global Clinical Trial Imaging Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)

8 Global Clinical Trial Imaging Market – By Product and Service (Market Size – & million/billion)
8.1 System and Technology Support
8.2 Project and Data Management
8.3 Clinical Trial Design and Consultation
8.4 Reading and Analytical
8.5 Operational Imaging

9 Global Clinical Trial Imaging Market – By Modality
9.1 X-Ray
9.2 Computed Tomography
9.3 Positron Emission Tomography
9.4 Magnetic Resonance Imaging
9.5 Ultrasound
9.6 Echocardiography
9.7 Other

10 Global Clinical Trial Imaging Market – By End-User
10.1 Medical Device Manufacturers
10.2 Contract Research Organizations
10.3 Pharmaceutical Companies
10.4 Biotechnology Companies
10.5 Academic and Government Research Institutes
10.6 Other

11 Global Clinical Trial Imaging Market – By Geography (Market Size – & million/billion)
11.1 Introduction
11.2 North America
11.2.1 US
11.2.2 Canada
11.2.3 Mexico
11.3 Europe
11.3.1 U.K
11.3.2 Germany
11.3.3 Italy
11.3.4 France
11.3.5 Spain
11.3.6 Rest of Europe
11.4 Asia-Pacific
11.4.1 China
11.4.2 Japan
11.4.3 India
11.4.4 South Korea
11.4.5 Rest of APAC
11.5 Rest of the World
11.5.1 South America
11.5.2 Middle East
11.5.3 Africa

12 Global Clinical Trial Imaging Market – Entropy
12.1 New product launches
12.2 M&A’s, collaborations, JVs and partnerships

13 Global Clinical Trial Imaging Market Company Profile (Key Players)
13.1 Market Share, Company Revenue, Products, M&A, Developments
13.2 Bioclinica, Inc.
13.3 Parexel International Corporation
13.4 Radiant Sage LLC
13.5 Worldcare Clinical, LLC
13.6 Icon PLC
13.7 Cardiovascular Imaging Technologies, LLC
13.8 Biomedical Systems Corporation
13.9 Biotelemetry, Inc.
13.10 Intrinsic Imaging LLC
13.11 Ixico PLC
13.12 Company 11 & more

14 Global Clinical Trial Imaging Market – Appendix
14.1 Sources
14.2 Abbreviations